Funding for this research was provided by:
Central South University (2021zzts0965)
National Natural Science Foundation of China (81973153)
Received: 2 November 2021
Accepted: 15 April 2022
First Online: 11 June 2022
: The cohort study has been performed in accordance with the Declaration of Helsinki. Written informed consent was provided by each participant’s caregiver or parent, and This cohort study was approved by the Independent Ethics Committee Institute of Clinical Pharmacology, Central South University, Changsha, China (Project number: CTXY-130041-3-2).
: Not applicable.
: The authors declare that they have no competing interests. Miss. Li wrote the first draft of the manuscript. No honorarium, grant, or other forms of payment was given to anyone to produce the manuscript.